Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase.
(2013) Molecular Cancer — Vol. 12, p. 33 (2013)
Files
Hellebrinanditsaglyconeformhellebrigenin.pdf
Restricted Access - Adobe PDF
- 1.18 MB
Details
- Authors
- Abstract
- Altogether, these data show that the binding affinity of the bufadienolides and cardenolides under study is usually higher for the α2β1 and α3β1 than for the α1β1 NaK complex, excepted for hellebrin and its aglycone form, hellebrigenin, with hellebrigenin being as potent as hellebrin in inhibiting in vitro cancer cell growth.
- Affiliations
Citations
Moreno Y Banuls, L., Katz, A., Miklos, W., Cimmino, A., Tal, D. M., Ainbinder, E., Zehl, M., Urban, E., Evidente, A., Kopp, B., Berger, W., Feron, O., Karlish, S., & Kiss, R. (2013). Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase. Molecular Cancer, 12, 33. https://doi.org/10.1186/1476-4598-12-33 (Original work published 2013)